2 April 2019 - - US-based Quanterix Corp. (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, has named Amol Chaubal to the position of chief financial officer, effective 12 April, the company said.

Amol replaces Joseph Driscoll, who is stepping down from his current role as CFO.

Amol brings over 20 years of experience, joining Quanterix from global medical technology company, Smith and Nephew, where he serves as CFO of Global Operations.

Prior to his time at Smith and Nephew, Amol served as corporate vice president and head of finance for Paraxel's CRS business.

He has also held various roles at Novartis, including CFO North America Vaccines and Diagnostics as well as international roles across Switzerland, Canada and the United States. Amol has a Master of Business Administration from INSEAD and a Master of Chemical Engineering from the Indian Institute of Technology.

Quanterix is a company that's digitizing biomarker analysis with the goal of advancing the science of precision health.

The company's digital health solution, Simoa, has the potential to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease.

Quanterix' technology is designed to enable much earlier disease detection, better prognoses and enhanced treatment methods to improve the quality of life and longevity of the population for generations to come.

The technology is currently being used for research applications in several therapeutic areas, including oncology, neurology, cardiology, inflammation and infectious disease. The company was established in 2007 and is located in Lexington, Massachusetts.